From the publishers of JADPRO

Metastatic Triple-Negative Breast Cancer Resource Center

Advertisement

Progress and Pitfalls in the Use of Immunotherapy for Patients With Triple Negative Breast Cancer

Last Updated: Thursday, November 3, 2022

This review examines the available evidence on the use of immunotherapeutic strategies in early and advanced TNBC, discusses the pitfalls and limitations often encountered in clinical research, and summarizes data on novel promising immunomodulatory approaches that have been explored in early-phase trials.

Expert Opinion on Investigational Drugs
Advertisement
News & Literature Highlights
Advertisement
Advertisement